Skip to main content
. 2021 Nov 13;24(3):483–494. doi: 10.1007/s12094-021-02708-4

Fig. 2.

Fig. 2

Decision-making algorithm in the administration of fluoropyrimidines in cancer patients. *Dose titration according to the toxicity observed. **Evaluate therapeutic alternatives